Femasys (FEMY) Operating Leases (2020 - 2026)
Femasys' (FEMY) quarterly Operating Leases came in at $795985.0 in Q2 2026, down 37.28% on a YoY basis from $1.3 million in Q2 2025, and down 12.77% quarter-over-quarter from $912534.0 in Q1 2026.
Analysis
Femasys (FEMY) Operating Leases (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported Operating Leases for 7 consecutive years, with $795985.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Leases fell 37.28% year-over-year to $795985.0; the trailing twelve-month figure through Jun 2026 stood at $795985.0 (down 37.28% YoY), and the FY2025 full-year result was $1.0 million, down 32.12% from the prior year.
- Operating Leases eased to $795985.0 in Q2 2026 per FEMY's latest filing, from $912534.0 in the prior quarter.
- Across five years, Operating Leases topped out at $2.2 million in Q3 2023 and bottomed at $28584.0 in Q4 2022.
- Historically, Operating Leases has averaged $1.1 million across 5 years, with a median of $1.2 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Operating Leases plunged 92.9% in 2022, then jumped 7023.1% in 2023.
- Over 5 years, Operating Leases stood at $28584.0 in 2022, then surged by 7023.1% to $2.0 million in 2023, then fell by 25.44% to $1.5 million in 2024, then tumbled by 32.12% to $1.0 million in 2025, then dropped by 22.76% to $795985.0 in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $795985.0, $912534.0, and $1.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 795,985.00 |
| Mar 31, 2026 | 912,534.00 |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 2.17 Mn |
| Dec 31, 2022 | 28,584.00 |
| Sep 30, 2022 | 115,773.00 |
| Jun 30, 2022 | 209,098.00 |
| Mar 31, 2022 | 305,071.00 |
| Dec 31, 2021 | 402,417.00 |
| Sep 30, 2021 | 501,912.00 |
| Jun 30, 2021 | 603,616.00 |
| Dec 31, 2020 | 809,092.00 |